ONCAlert | 2017 San Antonio Breast Cancer Symposium

Dr. Rimas Lukas on Searching for Biomarkers in Glioblastoma

Rimas Lukas, MD
Published Online:3:10 PM, Mon February 8, 2016


Rimas Lukas, MD, director, Medical Neuro-Oncology, co-director, Neurology Medical Student Clerkship Program, The University of Chicago Medical Center, discusses the next steps following a phase I study looking at atezolizumab in glioblastoma. Lukas says he hopes some of the results from this study will result in the revelation of new biomarkers in the immune checkpoint inhibitor world, as well as uncovering biomarkers that would reveal patients' abilities to either respond or not respond to certain treatments.

Lukas adds that other cancer types' expression of either PD-1 or PD-L1 have historically indicated which patients will respond to different treatment methods.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.